Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Runhan Liu"'
Autor:
Lei Zhao, Yu Wang, Ruxianguli Maimaitiyiming, Runhan Liu, Liang Wang, Ruoqing Liu, Keping Chen, Aihemaitijiang Aihaiti, Jingyang Hong
Publikováno v:
Food Chemistry: X, Vol 23, Iss , Pp 101748- (2024)
This study investigated the impact of three different charged hydrocolloids, anionic polysaccharide (soluble soybean polysaccharide, SSPS), neutral polysaccharide (pullulan polysaccharide, PUL), and cationic polysaccharide (chitosan, CS), and their c
Externí odkaz:
https://doaj.org/article/f96b4ba1b72a4608a39b8ba0592fc35b
Publikováno v:
Frontiers in Nutrition, Vol 11 (2024)
Precision nutrition and nutrigenomics are emerging in the development of therapies for multiple diseases. The ketogenic diet (KD) is the most widely used clinical diet, providing high fat, low carbohydrate, and adequate protein. KD produces ketones a
Externí odkaz:
https://doaj.org/article/5c971a32c1a244b6a008dfff93e92459
Autor:
Chenjing Fan, Shiqi Li, Yuxin Liu, Chenxi Jin, Lingling Zhou, Yueying Gu, Zhenyu Gai, Runhan Liu, Bing Qiu
Publikováno v:
Forests, Vol 14, Iss 8, p 1569 (2023)
While urban green spaces (UGSs) are important places for residents’ leisure activities, studies describing the long-term daily UGS usage of residents (including the total number of activities, the types of activities, and the touring experience) ha
Externí odkaz:
https://doaj.org/article/957557dd3c4b466cba1ac3c1febb95ef
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Plant-derived phytochemicals have gifted humans with vast therapeutic potentials. Yet, the unique features of the blood–brain barrier significantly limit their accession to the target tissue and thus clinical translation in brain disease treatment.
Externí odkaz:
https://doaj.org/article/c00135e1c6fc4b829915a16984b53f92
Publikováno v:
CNS Drugs. 37:231-242
Autor:
Ying Jin, Xiangjie Di, Lisha Fu, Mengyu Zhang, Neng Qiu, Runhan Liu, Fangqun Li, Xiaohui Qi, Xiaoxu Wang, Yongsheng Wang, Zhenlei Wang
Publikováno v:
Bioanalysis. 14:1165-1175
Background: JRF103, a novel pan-HER inhibitor, has shown potent activity against HER1, HER2, HER4 and EGFR in vitro. To support its first in-patient trial, a sensitive and rapid method was developed and validated using ultra-performance LC–MS/MS. M
Autor:
Qi Shen, Ying Jin, Xiangjie Di, Chao Hu, Runhan Liu, Ying Wang, Xiaohui Qi, Yongsheng Wang, Zhenlei Wang
Publikováno v:
Clinical Drug Investigation. 42:623-630
Erenumab is the first-in-class, selective, and competitive human monoclonal antibody antagonist of the calcitonin gene-related peptide (CGRP) receptor that has been shown to be effective and well-tolerated in the preventive therapy of episodic and ch
Autor:
Chaoqun He, Ying Jin, Yang Zhang, Mengyu Zhang, Xiangjie Di, Lisha Fu, Xiaohui Qi, Runhan Liu, Li Zheng, Zhenlei Wang, Jingdong Li, Faping Tu
Publikováno v:
European Journal of Clinical Pharmacology.
Autor:
Yi He, Ying Jin, Hen Xue, Runhan Liu, Mengyu Zhang, Ruoxi Liao, Maoli Chen, Xueli Zhou, Xueqin He, Min Qin, Kuo Li, Huiqun Zou, Ying Gan, Zhenlei Wang, Li Zheng, Hui Zhong, Ping Fu
Publikováno v:
Nephrology Dialysis Transplantation.
Background There is little information on the pharmacokinetics and pharmacodynamics of sacubitril/valsartan (SV) in patients undergoing peritoneal dialysis (PD) complicated with hypertension or heart failure (HF). This study was designed to evaluate
Autor:
Runhua Zhou, Runhan Liu
Publikováno v:
International Conference on Statistics, Data Science, and Computational Intelligence (CSDSCI 2022).